Syndax Pharmaceuticals
SNDX
SNDX
132 hedge funds and large institutions have $1.15B invested in Syndax Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
7% more funds holding
Funds holding: 123 → 132 (+9)
1.15% less ownership
Funds ownership: 100.92% → 99.77% (-1.1%)
Holders
132
Holding in Top 10
6
Calls
$5.77M
Puts
$825K
Top Buyers
| 1 | +$39.2M | |
| 2 | +$34.7M | |
| 3 | +$13.8M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$11.8M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$10.6M |
Top Sellers
| 1 | -$43.7M | |
| 2 | -$36.5M | |
| 3 | -$22.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.86M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$8.47M |